120
Participants
Start Date
August 1, 2025
Primary Completion Date
October 30, 2025
Study Completion Date
November 30, 2025
Standard Allergic Rhinitis Treatment
Participants will receive standard-of-care treatment for allergic rhinitis, including oral antihistamines and/or intranasal corticosteroids, according to current clinical guidelines. No additional supplementation will be provided in the control group. This arm serves as the comparator for evaluating the effects of probiotic and vitamin D supplementation
Combined Vitamin D and Probiotics Supplementation
Participants in this group will receive a combination therapy of Vitamin D3 plus a daily oral probiotic capsule containing a standardized blend of Lactobacillus and Bifidobacterium species. Both supplements will be administered once daily for 12 weeks. This intervention aims to assess the synergistic effect of vitamin D and probiotics on immune response and symptom relief in allergic rhinitis.
RECRUITING
Tanta University Hospital, ENT Department, Tanta
Tanta University
OTHER